ArticleJournal of pharmacy & bioallied sciences2026
Influence of the Gut Microbiome on Body Composition and Metabolic Risk in Indian Children with Type 1 Diabetes Mellitus (T1dm).
Article in Journal of pharmacy & bioallied sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The study aims to explore the gut flora presentation among Type 1 DM children with and without metabolic risks (MR) at a tertiary care center. Materials and Methods: A cross-sectional, observational study was conducted on children with T1DM (n = 68, mean-age = 12.9 years, disease-duration = 5.5 years, average HbA1c = 9.8%) divided into two groups based on with (n = 35) and without (n = 33) metabolic risk factors. Clinical-history, anthropometry, biochemical investigations, and body composition analysis was performed. Stool samples were collected; DNA extraction and targeted 16srRNA gene amplicon sequencing was performed. Results: Significant differences were observed in the relative abundance of gut microbiome at the family and genera level in children with metabolic risk as compared to without metabolic risk. Conclusion: Gut microbiome significantly differs in children with or without MR among T1DM cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.